Charles River Laboratories to acquire Galapagos’ Argenta and BioFocus service operations for up to €134 million
[Thomson Reuters ONE] – · Total cash consideration of up to €134 million o €129 million cash payment o earnout of €5 million upon achievement of revenue target after 12 months · Proceeds to be used to progress … moreView todays social media effects on CRLView the latest stocks trending across Twitter. Click to view dashboardSee who Charles is hiring […]